BioPharma Resources

Drug Trial Radar · NCT02779699

A Study of AL2846 on Tolerance and Pharmacokinetics

Phase I Study of Tolerance and Pharmacokinetics of AL2846 in Patients With Advanced Cancer

Last checked: Nov 19, 2026Latest source record: May 21, 2019 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknown

Status

Status unknown

Enrollment

20

Planned (sponsor's estimate)

Start

May 2016

Primary completion

Oct 2020

Study completion Oct 2020

Sponsor

Sponsor type
Industry
First posted
May 20, 2016

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A study of AL2846,a C-met/Hepatocyte growth factor tyrosine kinase inhibitor,in patients with advanced cancer.

Conditions

  • Advanced Cancer

Interventions

  • AL2846Drug

    AL2846 p.o. qd

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. The type of dose-limiting toxicity(ies) (DLT[s]) of AL2846Time frame: For 4 weeks for DLTs
  2. Pharmacokinetics of AL2846 (in plasma)Time frame: up to 28 Days (endpoint when the two consecutive time points of blood drug concentration <150 DPM/mL)
  3. The maximum tolerated dose (MTD) of AL2846Time frame: 48 weeks

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Cancer Institute and Hospital, Chinese Academy of Medical Sciences

    Beijing, Beijing Municipality, China · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.